14159, L.P. is Director & 10% Owner at GENOMIC HEALTH INC (GHDX). They have made 21 open-market trades across 6 companies since 2012, most recently 2019-06-14.
CIK 0001551138
10 open-market purchases totalling $450.3M since 2012, against 11 sales. Across 8 scored buys the stock is up 1.6% at ninety days, and 0.7 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 13% |
| Avg Move | -15.8% | -5.6% | +1.6% |
| Alpha | -11.7% | -4.8% | +0.7% |
| Scored | 8 | 8 | 8 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 36% | 64% | 82% |
| Avg Move | +0.4% | -2.1% | -5.0% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | SELL | 2019-04-12 | 2019-04-12 | $65.30 | $18.8M | +2.4% | -12.2% | -13.4% |
| GHDX | SELL | 2019-04-11 | 2019-04-12 | $65.96 | $32.3M | +2.4% | -12.2% | -13.4% |
| GHDX | SELL | 2019-04-11 | 2019-04-12 | $66.90 | $13.5M | +2.4% | -12.2% | -13.4% |
| GHDX | SELL | 2019-01-22 | 2019-01-22 | $71.00 | $3.7M | +6.6% | +9.6% | -11.2% |
| GHDX | SELL | 2019-01-11 | 2019-01-14 | $70.22 | $1.9M | +4.8% | +19.2% | -4.8% |
| GHDX | SELL | 2019-01-10 | 2019-01-14 | $70.23 | $2.8M | +4.8% | +19.2% | -4.8% |
| GHDX | SELL | 2019-01-10 | 2019-01-14 | $70.28 | $680K | +4.8% | +19.2% | -4.8% |
| GHDX | SELL | 2018-12-03 | 2018-12-03 | $78.49 | $15.9M | -9.7% | -19.0% | -0.4% |
| GHDX | SELL | 2018-12-03 | 2018-12-03 | $78.50 | $15.7M | -9.7% | -19.0% | -0.4% |
| ACAD | BUY | 2018-11-30 | 2018-12-04 | $17.00 | $200.0M | -5.9% | -13.3% | +43.9% |
| GHDX | SELL | 2018-11-08 | 2018-11-13 | $86.50 | $6.6M | -2.4% | -8.1% | +5.7% |
| GHDX | SELL | 2018-11-08 | 2018-11-13 | $86.52 | $6.4M | -2.4% | -8.1% | +5.7% |
| SGEN | BUY | 2014-12-08 | 2014-12-10 | $33.82 | $42.2M | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2014-11-06 | 2014-11-10 | $34.56 | $57.2M | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2014-06-05 | 2014-06-09 | $38.16 | $20.8M | -17.1% | -4.5% | -4.5% |
| GEVA | BUY | 2013-09-25 | 2013-09-27 | $56.63 | $59.5M | N/A | N/A | N/A |
| BCRX | BUY | 2013-08-01 | 2013-08-02 | $4.40 | $5.0M | -26.4% | -2.7% | -2.7% |
| GHDX | BUY | 2013-05-28 | 2013-05-29 | $36.89 | $4.5M | -10.0% | -1.8% | -1.8% |
| GEVA | BUY | 2013-01-04 | 2013-01-08 | $47.53 | $40.9M | N/A | N/A | N/A |
| GHDX | BUY | 2012-11-20 | 2012-11-23 | $26.83 | $6.2M | -10.0% | -1.8% | -1.8% |
| XOMA | BUY | 2012-10-29 | 2012-10-31 | $3.00 | $14.2M | -22.4% | -11.6% | -11.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| BCRX | 145,533 | $1.1M |
| GEVA | 7,806,552 | — |
| Total | $6.3B |
Shares reported on the most recent Form 4, priced at the 2019-06-18 close. 1 holding could not be priced and is excluded from the total.
| Scored | 11 | 11 | 11 |